Shanghai, China and Catania, Italy - March 31, 2021. AffaMed Therapeutics (“AffaMed”), a global clinical-stage biopharmaceutical company dedicated to addressing critical unmet patient need in ophthalmic, neurological and psychiatric disor...

> leggi

Leading ophthalmic products, including NETILDEX®, NETIRA® and EYESTIL® will soon be marketed directly by SIFI Ilaç. Catania, Italy - March 22, 2021 – SIFI, a leading ophthalmic company, is pleased to announce that the Turk...

> leggi

Polihexanide 0.08% Exhibits Compelling Safety and Tolerability Characteristics in Healthy Volunteers. Catania, Italy – February 2, 2021 – SIFI, a leading ophthalmic company, announced today the publication of clinical results from its ...

> leggi

The innovative formulation enlarges the company’s dry eye portfolio Catania, Italy – Jan 7, 2021 – SIFI, a leading international ophthalmic company, announces the launch of SYNFO, a novel medical device representing the latest ad...

> leggi

Spectacle-free uninterrupted high-quality vision for cataract patients Catania, Italy – Dec 21, 2020 – SIFI, a leading international eye care company, today announces the launch of the WELL FUSION™ system and the Mini WELL PROXA&...

> leggi